Maria  Kaparakis-Liaskos

Maria Kaparakis-Liaskos


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2015 in Nature Reviews Immunology
Verified
Journal Article
Closed access
MKMaria Kaparakis-Liaskos
Maria Kaparakis-Liaskos
RFRichard L. Ferrero
Richard L. Ferrero

17 March 2023 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
MTMasanori Toyofuku
Masanori Toyofuku
SSStefan Schild
Stefan Schild
MKMaria Kaparakis-Liaskos
Maria Kaparakis-Liaskos
LELeo Eberl
Leo Eberl

1 May 2014 in Cell Host & Microbe
Verified
Journal Article
Closed access
AIAaron T. Irving
Aaron T. Irving
HMHitomi Mimuro
Hitomi Mimuro
TKThomas A. Kufer
Thomas A. Kufer
CLCamden Lo
Camden Lo
RWRichard Wheeler
Richard Wheeler
MKMaria Kaparakis-Liaskos
Maria Kaparakis-Liaskos

2 July 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LTLorinda Turner
Lorinda Turner
NBNatalie J. Bitto
Natalie J. Bitto
DSDavid L. Steer
David L. Steer
CLCamden Lo
Camden Lo
KDKimberley D’cOsta
Kimberley D’cOsta
MKMaria Kaparakis-Liaskos
Maria Kaparakis-Liaskos
Gram-negative pathogens ubiquitously shed outer membrane vesicles (OMVs) that play a central role in initiating and regulating pathogenesis in the host. Due to their highly inflammatory nature, OMVs are extensively being examined for their role in mediating disease in addition to their applications in innovative vaccines. A key mechanism whereby OMVs mediate inflammation and disease progression is dependent on their ability to enter host cells. Currently, the role of OMV size on determining their mechanism of cellular entry and their protein composition remains unknown. In this study, we examined the mechanisms whereby OMV size regulates their mode of entry into epithelial cells, in addition to their protein cargo and composition. We identified that a heterogeneous sized population of Helicobacter pylori OMVs entered epithelial cells via macropinocytosis, clathrin, and caveolin-dependent endocytosis. However, smaller OMVs ranging from 20 to 100 nm in size preferentially entered host cells via caveolin-mediated endocytosis. Whereas larger OMVs ranging between 90 and 450 nm in size entered host epithelial cells via macropinocytosis and endocytosis. Most importantly, we identified the previously unknown contribution that OMV size has on determining their protein content, as fewer and less diverse bacterial proteins were contained within small OMVs compared to larger OMVs. Collectively, these findings identify the importance of OMV size in determining the mechanisms of OMV entry into host cells, in addition to regulating their protein cargo, composition, and subsequent immunogenicity. These findings have significant implications in broadening our understanding of the bacterial regulation of virulence determinants and immunogenic proteins associated with OMVs, their role in mediating pathogenesis and in refining the design and development of OMV-based vaccines.

25 September 2016 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
RPRishi D. Pathirana
Rishi D. Pathirana
MKMaria Kaparakis-Liaskos
Maria Kaparakis-Liaskos
Outer membrane vesicles were first described approximately 50 years ago and for many years were considered to be an artifact of bacterial growth. Since that initial discovery, it has become evident that outer membrane vesicles are produced by almost all Gram-negative bacteria as part of their normal growth in addition to driving pathogenesis within the host. More recently, the identification of membrane vesicle (MV) production by some Gram-positive bacteria, parasites, fungi, mycobacteria and infected host cells has significantly broadened the field of MV research and emphasized their importance to pathogenesis. In this review, we will focus on discussing recent advances in the field of bacterial MV biogenesis and the mechanisms whereby they modulate immunity and contribute to pathogenesis. We will highlight findings identifying the contribution of extracellular vesicles produced by Gram-positive bacteria, fungi, parasites, and infected host cells in mediating pathogenesis in addition to the functions of MVs produced by commensal bacteria. Finally, we will discuss recent progress in the development of bacterial MVs as novel vaccines capable of mediating cellular and humoral immune responses.

7 June 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Michael GantierMichael Gantier
Michael Gantier
HSH. James Stunden
H. James Stunden
CMClaire McCoy
Claire McCoy
MBMark A. Behlke
Mark A. Behlke
DWDie Wang
Die Wang
BWBryan Raymond George Williams
Bryan Raymond George Williams
Fine-tuning of inflammatory responses by microRNAs (miRNAs) is complex, as they can both enhance and repress expression of pro-inflammatory mediators. In this study, we investigate inflammatory responses following global miRNA depletion, to better define the overall contribution of miRNAs to inflammation. We demonstrate that miRNAs positively regulate Toll-like receptor signaling using inducible Dicer1 deletion and global miRNA depletion. We establish an important contribution of miR-19b in this effect, which potentiates nuclear factor-κB (NF-κB) activity in human and mouse cells. Positive regulation of NF-κB signaling by miR-19b involves the coordinated suppression of a regulon of negative regulators of NF-κB signaling (including A20/Tnfaip3, Rnf11, Fbxl11/Kdm2a and Zbtb16). Transfection of miR-19b mimics exacerbated the inflammatory activation of rheumatoid arthritis primary fibroblast-like synoviocytes, demonstrating its physiological importance in the pathology of this disease. This study constitutes, to our knowledge, the first description of a miR-19 regulon that controls NF-κB signaling, and suggests that targeting this miRNA and linked family members could regulate the activity of NF-κB signaling in inflammation.